BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

504 related articles for article (PubMed ID: 21560834)

  • 1. Blood glucose patterns in type 2 diabetic patients with optimal fasting plasma glucose but high HbA1c.
    Charoenhirunyingyos W; Nitiyanant W; Thabsang P; Sriussadaporn S; Vannasaeng S
    J Med Assoc Thai; 2011 Mar; 94(3):278-85. PubMed ID: 21560834
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Contribution of post-breakfast plasma glucose to the glycemic control of type 2 diabetic patients].
    Sartori MS; Aragon FF; Padovani CR; Pimenta Wde P
    Arq Bras Endocrinol Metabol; 2006 Feb; 50(1):53-9. PubMed ID: 16628275
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glycemic Profiling in Patients with Drug-Naïve Type 2 Diabetes by Continuous Glucose Monitoring.
    Mori H; Okada Y; Kawaguchi M; Otsuka T; Miyazaki M; Sonoda S; Sugai K; Uemura F; Tanaka K; Hajime M; Kurozumi A; Narisawa M; Torimoto K; Tanaka Y
    J UOEH; 2018; 40(4):287-297. PubMed ID: 30568080
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of Fasting Glucose Levels on Achieving Glycemic Target in Individuals with Type 2 Diabetes: a Post Hoc Analysis.
    Ma J; Lei M; Li Y; Zhang X; Cui N; Yang W
    Adv Ther; 2020 Sep; 37(9):3816-3826. PubMed ID: 32671687
    [TBL] [Abstract][Full Text] [Related]  

  • 5. FASTING VERSUS POSTPRANDIAL HYPERGLYCEMIA AS A TREATMENT TARGET TO LOWER ELEVATED HEMOGLOBIN A1C.
    Shaefer C; Reid T; Vlajnic A; Zhou R; DiGenio A
    Endocr Pract; 2015 Dec; 21(12):1323-32. PubMed ID: 26307902
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relationship between fasting plasma glucose and glycosylated hemoglobin: potential for false-positive diagnoses of type 2 diabetes using new diagnostic criteria.
    Davidson MB; Schriger DL; Peters AL; Lorber B
    JAMA; 1999 Apr; 281(13):1203-10. PubMed ID: 10199430
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of fasting and postprandial glycemia on overall glycemic control in type 2 diabetes Importance of postprandial glycemia to achieve target HbA1c levels.
    Woerle HJ; Neumann C; Zschau S; Tenner S; Irsigler A; Schirra J; Gerich JE; Göke B
    Diabetes Res Clin Pract; 2007 Aug; 77(2):280-5. PubMed ID: 17240473
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Postprandial peaks as a risk factor for cardiovascular disease: epidemiological perspectives.
    Bonora E
    Int J Clin Pract Suppl; 2002 Jul; (129):5-11. PubMed ID: 12166607
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Unrecognized hypo- and hyperglycemia in well-controlled patients with type 2 diabetes mellitus: the results of continuous glucose monitoring.
    Hay LC; Wilmshurst EG; Fulcher G
    Diabetes Technol Ther; 2003; 5(1):19-26. PubMed ID: 12725703
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical significance of targeting postprandial and fasting hyperglycemia in managing type 2 diabetes mellitus.
    Fonseca V
    Curr Med Res Opin; 2003; 19(7):635-41. PubMed ID: 14606987
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Distribution of blood glucose and the correlation between blood glucose and hemoglobin A1c levels in diabetic outpatients.
    Yamamoto-Honda R; Kitazato H; Hashimoto S; Takahashi Y; Yoshida Y; Hasegawa C; Akanuma Y; Noda M
    Endocr J; 2008 Oct; 55(5):913-23. PubMed ID: 18612182
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fasting and post-prandial glycemia and their correlation with glycated hemoglobin in Type 2 diabetes.
    Monami M; Lamanna C; Lambertucci L; Longo R; Cocca C; Addante F; Lotti E; Masotti G; Marchionni N; Mannucci E
    J Endocrinol Invest; 2006; 29(7):619-24. PubMed ID: 16957410
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy, safety, and dose-response characteristics of glipizide gastrointestinal therapeutic system on glycemic control and insulin secretion in NIDDM. Results of two multicenter, randomized, placebo-controlled clinical trials. The Glipizide Gastrointestinal Therapeutic System Study Group.
    Simonson DC; Kourides IA; Feinglos M; Shamoon H; Fischette CT
    Diabetes Care; 1997 Apr; 20(4):597-606. PubMed ID: 9096986
    [TBL] [Abstract][Full Text] [Related]  

  • 14. How valid is fasting plasma glucose as a parameter of glycemic control in non-insulin-using patients with type 2 diabetes?
    Bouma M; Dekker JH; de Sonnaville JJ; van der Does FE; de Vries H; Kriegsman DM; Kostense PJ; Heine RJ; van Eijk JT
    Diabetes Care; 1999 Jun; 22(6):904-7. PubMed ID: 10372239
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Validation of diagnostic utility of fasting plasma glucose and HbA1c in stable renal transplant recipients one year after transplantation.
    Ussif AM; Åsberg A; Halden TAS; Nordheim E; Hartmann A; Jenssen T
    BMC Nephrol; 2019 Jan; 20(1):12. PubMed ID: 30630438
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A global study of the unmet need for glycemic control and predictor factors among patients with type 2 diabetes mellitus who have achieved optimal fasting plasma glucose control on basal insulin.
    Raccah D; Chou E; Colagiuri S; Gaàl Z; Lavalle F; Mkrtumyan A; Nikonova E; Tentolouris N; Vidal J; Davies M
    Diabetes Metab Res Rev; 2017 Mar; 33(3):. PubMed ID: 27606888
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnostic and therapeutic implications of relationships between fasting, 2-hour postchallenge plasma glucose and hemoglobin a1c values.
    Woerle HJ; Pimenta WP; Meyer C; Gosmanov NR; Szoke E; Szombathy T; Mitrakou A; Gerich JE
    Arch Intern Med; 2004 Aug 9-23; 164(15):1627-32. PubMed ID: 15302632
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of carbohydrate restriction in the first meal after an overnight fast on glycemic control in people with type 2 diabetes: a randomized trial.
    Pedersen E; Lange K; Clifton P
    Am J Clin Nutr; 2016 Nov; 104(5):1285-1291. PubMed ID: 27733405
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Correlation between fasting plasma glucose, post prandial glucose and glycated haemoglobin and fructosamine.
    Rosediani M; Azidah AK; Mafauzy M
    Med J Malaysia; 2006 Mar; 61(1):67-71. PubMed ID: 16708736
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Confirming glycemic status in the Diabetes Prevention Program: implications for diagnosing diabetes in high risk adults.
    Christophi CA; Resnick HE; Ratner RE; Temprosa M; Fowler S; Knowler WC; Shamoon H; Barrett-Connor E; Kahn SE;
    J Diabetes Complications; 2013; 27(2):150-7. PubMed ID: 23140912
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.